Experts and patients have urged to measure the quality of life in the evaluation and financing of oncological treatments, integrating the patient's perspective, with the aim of going beyond survival and evaluating physical factors, mental and emotional health, autonomy or side effects of therapies.
Experts and patients have urged to measure the quality of life in the evaluation and financing of oncological treatments, integrating the patient's perspective, with the aim of going beyond survival and evaluating physical factors, mental and emotional health, autonomy or side effects of therapies.